Total Funding
40
Total FundingSeed raised
Growth Score
pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Dorna Therapeutics is the first company to stimulate both innate and adaptive immune responses directly and selectively.
Mousa Jafari: Co-Founder, President, Chief Executive Officer & Board Member
About the Company
Dorna Therapeutics is the first company to stimulate both innate and adaptive immune responses directly and selectively within solid tumors to create a universal therapeutic cancer vaccine. The systemic administration of a single drug compound with tumor accumulating capabilities will allow patients to immunize themselves against their own cancers
for a long lasting curative effect.
